FindTrial
Sign In

Comparison of efficiency of Ketamine and Dexmedetomidine on their addition to Bupivacaine to provide pain relief during upper limb surgeries.

Effect of Ketamine and Dexmedetomidine as adjuvant to Bupivacaine on onset and duration of Supraclavicular brachial plexus block-A comparative study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020658
Enrollment
60
Registered
2019-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M974- Periprosthetic fracture around internal prosthetic elbow joint Health Condition 2: S529- Unspecified fracture of forearm

Interventions

Intervention1: KETAMINE 2milligram per kg: To study the effect of KETAMINE as adjuvant to BUPIVACAINE on onset and duration of SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK.Total duration of therapy will be f

Sponsors

IMS BHU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS undergoing various elective surgeries under supraclavicular block.

Exclusion criteria

Exclusion criteria: ASA class 3 and 4,patients refusal,coagulopathy,neurological deficits involving brachial plexus,patients allergic to local anesthetic,dexmedetomidine and ketamine,local infection at infection site,patients on any sedative or antipsychotics,hepatic and renal impairment,severe obesity,pregnancy,neuropathy,hemodynamic unstability

Design outcomes

Primary

MeasureTime frame
onset of sensory block,onset of motor block,post surgery pain score(VAS),duration of sensory and motor block,duration of analgesia,sedation scoreTimepoint: 0.5hours,1hour,2hour—

Secondary

MeasureTime frame
post surgery pain score(VAS),duration of analgesia,duration of motor block,duration of sensory blockTimepoint: 4 hour,5hour—

Countries

India

Contacts

Public ContactDr Manjaree Mishra

IMS,BHU

drmanjareemd@gmail.com9452030626

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026